Corynebacterium striatum is part of the average human skin flora and mucous membranes. However, it has emerged as an important opportunistic pathogen that can cause infections in immunocompromised individuals, especially those with underlying medical conditions. Here are some critical facts about the epidemiology of Corynebacterium striatum.
Infections: Corynebacterium striatum is primarily associated with infections of the respiratory tract, bloodstream, skin and soft tissues, and bone and joints. It is also commonly isolated from catheter-related infections and endocarditis.
Nosocomial infections: Most infections caused by Corynebacterium striatum are nosocomial or healthcare-associated infections. These infections occur in patients hospitalized for a prolonged period, underwent invasive procedures, or received broad-spectrum antibiotics.
Prevalence: The prevalence of Corynebacterium striatum varies depending on the population being studied and the type of infection being investigated. Studies have reported prevalence rates ranging from 0.1% to 15% in clinical specimens.
Risk factors: Corynebacterium striatum infections include immunosuppression, long-term hospitalization, invasive procedures, indwelling catheters, and broad-spectrum antibiotics.
Treatment: Corynebacterium striatum is typically resistant to penicillin and other beta-lactam antibiotics. It is susceptible to certain antibiotics such as vancomycin, daptomycin, linezolid, and tigecycline. However, antibiotic resistance is becoming increasingly common among clinical isolates.
Corynebacterium striatum is a Gram-positive, aerobic, non-spore-forming bacterium belonging to the Corynebacterium genus. It was first identified in 1993 and is commonly found in the environment and the skin, respiratory tract, and gastrointestinal tract of humans.
Structure:C. striatum is a rod-shaped bacterium that ranges from 0.5 to 0.8 µm in diameter and 1.5 to 5 µm in length. It has a cell wall composed of peptidoglycan, arabinogalactan, and mycolic acids, which gives it a characteristic “club-like” shape. The mycolic acid in the cell wall makes it resistant to many disinfectants and antibiotics.
Classification: C. striatum is a member of the phylum Actinobacteria, class Actinobacteria, order Corynebacteriales, family Corynebacteriaceae, and genus Corynebacterium. It is closely related to Corynebacterium species, such as C. diphtheriae, C. pseudotuberculosis, and C. ulcerans.
C. Striatum can be further classified into biotypes and ribotypes based on its biochemical and genetic characteristics. There are currently nine known biotypes and 13 ribotypes of C. striatum identified, which can be differentiated by their ability to utilize different carbon sources and the genetic diversity of their 16S rRNA genes, respectively.
There are several antigenic types of Corynebacterium striatum, which their specific serotypes can identify. Serotyping is based on specific antigens on the bacterial surface, which can be detected using antibodies. Several serotyping methods exist, including agglutination tests, enzyme-linked immunosorbent assays (ELISAs), and Western blotting.
Which depends on whether something is present or not in specific surface proteins. These types include:
Type A: This type is characterized by the presence of the OmpA, an outer membrane protein.
Type B: This type is characterized by the presence of the protein P48, which is a cell surface protein.
Type C: This type is characterized by the presence of the protein FimA, which is a fimbrial protein.
Type D: This type is characterized by the absence of all three proteins (OmpA, P48, and FimA).
Corynebacterium striatum is a gram-positive, aerobic, non-spore-forming bacterium that is a part of the normal microbiota of human skin and mucous membranes. It is regarded as an opportunistic pathogen; in most cases, it rarely results in sickness in healthy persons. But can cause infections in immunocompromised individuals or those with underlying medical conditions.
The pathogenesis of C. striatum is poorly understood, although it is believed to be associated with the production of virulence factors such as adhesins, invasins, and toxins. Adhesins are molecules that allow the bacteria to adhere to host cells and tissues, while invasins facilitate the entry of the bacteria into host cells. Toxins produced by C. striatum can cause tissue damage and contribute to disease development.
C. Striatum is known to cause various infections, including skin and soft tissue infections, bloodstream infections, and pneumonia. The bacterium is often resistant to multiple antibiotics, making it difficult to treat.
One study found that C. striatum could form biofilms, communities of bacteria that attach to surfaces and resist antibiotics and the host’s immune response. Biofilm formation may contribute to the ability of C. striatum to cause persistent infections.
In conclusion, the pathogenesis of C. striatum is complex and poorly understood, but it is thought to involve the production of virulence factors such as adhesins, invasins, and toxins. The ability of the bacterium to form biofilms may also contribute to its pathogenicity.
The typical microbial flora of the skin and mucous membranes includes Corynebacterium striatum. While it is typically considered a non-pathogenic bacterium, C. striatum has been known to cause opportunistic infections in immunocompromised individuals.
The host defenses against C. striatum include both innate and adaptive immune responses. The initial line of protection against pathogens is the innate immune system. Invading pathogens and is responsible for the initial recognition and response to C. striatum.
The innate immune response to C. striatum includes the activation of various pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which recognize pathogen-associated molecular patterns (PAMPs) present on the surface of the bacteria.
This recognition leads to the activation of downstream signaling pathways, producing pro-inflammatory cytokines and chemokines, recruitment of phagocytic cells, and induction of oxidative burst to destroy the bacteria.
The adaptive immune response to C. striatum involves the activation of T and B lymphocytes, which recognize and respond to specific antigens present on the surface of the bacteria. It leads to the production of specific antibodies and the activation of T cells, which can directly kill infected cells or release cytokines that promote the clearance of the bacteria.
In addition to the immune response, host defenses against C. striatum include physical and mechanical barriers, such as the skin and mucous membranes, preventing the bacteria from entering the body. Furthermore, the normal microbial flora of the skin and mucous membranes can compete with C. striatum for nutrients and space, limiting its growth and colonization.
Here are some clinical manifestations of C. striatum infections:
Skin and soft tissue infections: C. striatum can cause cellulitis, abscesses, and wound infections. These infections can be challenging to treat because Several antibiotics frequently fail to kill C. striatum.
Urinary tract infections: C. striatum can cause urinary tract infections in individuals with urinary catheters or other abnormalities.
Respiratory tract infections: C. striatum can cause pneumonia in immunocompromised individuals or have underlying lung disease.
Endocarditis: C. striatum can cause infective endocarditis, an infection of the heart valves. It is a severe condition that requires prompt treatment.
Bacteremia: C. striatum can cause bloodstream infections, leading to sepsis if not treated promptly.
C. Striatum infection can be diagnosed through various methods, including culture, microscopy, biochemical tests, and molecular techniques such as PCR (polymerase chain reaction) and sequencing.
Culture is the most common method used to diagnose C. striatum infection. The bacteria can be grown on various media, including blood, chocolate, and MacConkey agar. The colonies typically appear gray or yellowish and have a “club-shaped” morphology.
Microscopy can also visualize the bacteria, although it is less commonly used than culture. Gram staining can be performed to identify the bacteria as Gram-positive, and the club-shaped morphology can be seen under a microscope.
Biochemical tests can also be used to identify C. striatum. The bacteria are catalase-positive, oxidase-negative, and urease-negative. They also produce acid from glucose and maltose but not from lactose or sucrose.
PCR and sequencing can also identify C. striatum. PCR can be used to amplify specific DNA sequences unique to the bacteria, and sequencing can be used to compare the DNA sequence to known C. striatum sequences in databases.
Corynebacterium striatum is a type of bacteria that can cause infections in humans, especially in immunocompromised individuals. Here are some ways to control its spread:
Hand hygiene: Regularly washing your hands Using alcohol-based hand sanitizer or soap and water can help prevent the spread of C. striatum.
Isolation precautions: Patients infected with C. striatum should be segregated in a private room, and medical personnel caring for patients should wear gloves and gowns.
Antibiotic stewardship: Overusing antibiotics can develop antibiotic-resistant strains of C. striatum. Thus it’s essential only to use antibiotics when necessary.
Environmental cleaning: Frequent cleaning and disinfection of surfaces and equipment can help prevent the spread of C. striatum.
Education and awareness: Healthcare workers and the general public should be educated about the risks associated with C. striatum infections and the measures that can be taken to prevent their spread.
Corynebacterium striatum is part of the average human skin flora and mucous membranes. However, it has emerged as an important opportunistic pathogen that can cause infections in immunocompromised individuals, especially those with underlying medical conditions. Here are some critical facts about the epidemiology of Corynebacterium striatum.
Infections: Corynebacterium striatum is primarily associated with infections of the respiratory tract, bloodstream, skin and soft tissues, and bone and joints. It is also commonly isolated from catheter-related infections and endocarditis.
Nosocomial infections: Most infections caused by Corynebacterium striatum are nosocomial or healthcare-associated infections. These infections occur in patients hospitalized for a prolonged period, underwent invasive procedures, or received broad-spectrum antibiotics.
Prevalence: The prevalence of Corynebacterium striatum varies depending on the population being studied and the type of infection being investigated. Studies have reported prevalence rates ranging from 0.1% to 15% in clinical specimens.
Risk factors: Corynebacterium striatum infections include immunosuppression, long-term hospitalization, invasive procedures, indwelling catheters, and broad-spectrum antibiotics.
Treatment: Corynebacterium striatum is typically resistant to penicillin and other beta-lactam antibiotics. It is susceptible to certain antibiotics such as vancomycin, daptomycin, linezolid, and tigecycline. However, antibiotic resistance is becoming increasingly common among clinical isolates.
Corynebacterium striatum is a Gram-positive, aerobic, non-spore-forming bacterium belonging to the Corynebacterium genus. It was first identified in 1993 and is commonly found in the environment and the skin, respiratory tract, and gastrointestinal tract of humans.
Structure:C. striatum is a rod-shaped bacterium that ranges from 0.5 to 0.8 µm in diameter and 1.5 to 5 µm in length. It has a cell wall composed of peptidoglycan, arabinogalactan, and mycolic acids, which gives it a characteristic “club-like” shape. The mycolic acid in the cell wall makes it resistant to many disinfectants and antibiotics.
Classification: C. striatum is a member of the phylum Actinobacteria, class Actinobacteria, order Corynebacteriales, family Corynebacteriaceae, and genus Corynebacterium. It is closely related to Corynebacterium species, such as C. diphtheriae, C. pseudotuberculosis, and C. ulcerans.
C. Striatum can be further classified into biotypes and ribotypes based on its biochemical and genetic characteristics. There are currently nine known biotypes and 13 ribotypes of C. striatum identified, which can be differentiated by their ability to utilize different carbon sources and the genetic diversity of their 16S rRNA genes, respectively.
There are several antigenic types of Corynebacterium striatum, which their specific serotypes can identify. Serotyping is based on specific antigens on the bacterial surface, which can be detected using antibodies. Several serotyping methods exist, including agglutination tests, enzyme-linked immunosorbent assays (ELISAs), and Western blotting.
Which depends on whether something is present or not in specific surface proteins. These types include:
Type A: This type is characterized by the presence of the OmpA, an outer membrane protein.
Type B: This type is characterized by the presence of the protein P48, which is a cell surface protein.
Type C: This type is characterized by the presence of the protein FimA, which is a fimbrial protein.
Type D: This type is characterized by the absence of all three proteins (OmpA, P48, and FimA).
Corynebacterium striatum is a gram-positive, aerobic, non-spore-forming bacterium that is a part of the normal microbiota of human skin and mucous membranes. It is regarded as an opportunistic pathogen; in most cases, it rarely results in sickness in healthy persons. But can cause infections in immunocompromised individuals or those with underlying medical conditions.
The pathogenesis of C. striatum is poorly understood, although it is believed to be associated with the production of virulence factors such as adhesins, invasins, and toxins. Adhesins are molecules that allow the bacteria to adhere to host cells and tissues, while invasins facilitate the entry of the bacteria into host cells. Toxins produced by C. striatum can cause tissue damage and contribute to disease development.
C. Striatum is known to cause various infections, including skin and soft tissue infections, bloodstream infections, and pneumonia. The bacterium is often resistant to multiple antibiotics, making it difficult to treat.
One study found that C. striatum could form biofilms, communities of bacteria that attach to surfaces and resist antibiotics and the host’s immune response. Biofilm formation may contribute to the ability of C. striatum to cause persistent infections.
In conclusion, the pathogenesis of C. striatum is complex and poorly understood, but it is thought to involve the production of virulence factors such as adhesins, invasins, and toxins. The ability of the bacterium to form biofilms may also contribute to its pathogenicity.
The typical microbial flora of the skin and mucous membranes includes Corynebacterium striatum. While it is typically considered a non-pathogenic bacterium, C. striatum has been known to cause opportunistic infections in immunocompromised individuals.
The host defenses against C. striatum include both innate and adaptive immune responses. The initial line of protection against pathogens is the innate immune system. Invading pathogens and is responsible for the initial recognition and response to C. striatum.
The innate immune response to C. striatum includes the activation of various pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which recognize pathogen-associated molecular patterns (PAMPs) present on the surface of the bacteria.
This recognition leads to the activation of downstream signaling pathways, producing pro-inflammatory cytokines and chemokines, recruitment of phagocytic cells, and induction of oxidative burst to destroy the bacteria.
The adaptive immune response to C. striatum involves the activation of T and B lymphocytes, which recognize and respond to specific antigens present on the surface of the bacteria. It leads to the production of specific antibodies and the activation of T cells, which can directly kill infected cells or release cytokines that promote the clearance of the bacteria.
In addition to the immune response, host defenses against C. striatum include physical and mechanical barriers, such as the skin and mucous membranes, preventing the bacteria from entering the body. Furthermore, the normal microbial flora of the skin and mucous membranes can compete with C. striatum for nutrients and space, limiting its growth and colonization.
Here are some clinical manifestations of C. striatum infections:
Skin and soft tissue infections: C. striatum can cause cellulitis, abscesses, and wound infections. These infections can be challenging to treat because Several antibiotics frequently fail to kill C. striatum.
Urinary tract infections: C. striatum can cause urinary tract infections in individuals with urinary catheters or other abnormalities.
Respiratory tract infections: C. striatum can cause pneumonia in immunocompromised individuals or have underlying lung disease.
Endocarditis: C. striatum can cause infective endocarditis, an infection of the heart valves. It is a severe condition that requires prompt treatment.
Bacteremia: C. striatum can cause bloodstream infections, leading to sepsis if not treated promptly.
C. Striatum infection can be diagnosed through various methods, including culture, microscopy, biochemical tests, and molecular techniques such as PCR (polymerase chain reaction) and sequencing.
Culture is the most common method used to diagnose C. striatum infection. The bacteria can be grown on various media, including blood, chocolate, and MacConkey agar. The colonies typically appear gray or yellowish and have a “club-shaped” morphology.
Microscopy can also visualize the bacteria, although it is less commonly used than culture. Gram staining can be performed to identify the bacteria as Gram-positive, and the club-shaped morphology can be seen under a microscope.
Biochemical tests can also be used to identify C. striatum. The bacteria are catalase-positive, oxidase-negative, and urease-negative. They also produce acid from glucose and maltose but not from lactose or sucrose.
PCR and sequencing can also identify C. striatum. PCR can be used to amplify specific DNA sequences unique to the bacteria, and sequencing can be used to compare the DNA sequence to known C. striatum sequences in databases.
Corynebacterium striatum is a type of bacteria that can cause infections in humans, especially in immunocompromised individuals. Here are some ways to control its spread:
Hand hygiene: Regularly washing your hands Using alcohol-based hand sanitizer or soap and water can help prevent the spread of C. striatum.
Isolation precautions: Patients infected with C. striatum should be segregated in a private room, and medical personnel caring for patients should wear gloves and gowns.
Antibiotic stewardship: Overusing antibiotics can develop antibiotic-resistant strains of C. striatum. Thus it’s essential only to use antibiotics when necessary.
Environmental cleaning: Frequent cleaning and disinfection of surfaces and equipment can help prevent the spread of C. striatum.
Education and awareness: Healthcare workers and the general public should be educated about the risks associated with C. striatum infections and the measures that can be taken to prevent their spread.
Corynebacterium striatum is part of the average human skin flora and mucous membranes. However, it has emerged as an important opportunistic pathogen that can cause infections in immunocompromised individuals, especially those with underlying medical conditions. Here are some critical facts about the epidemiology of Corynebacterium striatum.
Infections: Corynebacterium striatum is primarily associated with infections of the respiratory tract, bloodstream, skin and soft tissues, and bone and joints. It is also commonly isolated from catheter-related infections and endocarditis.
Nosocomial infections: Most infections caused by Corynebacterium striatum are nosocomial or healthcare-associated infections. These infections occur in patients hospitalized for a prolonged period, underwent invasive procedures, or received broad-spectrum antibiotics.
Prevalence: The prevalence of Corynebacterium striatum varies depending on the population being studied and the type of infection being investigated. Studies have reported prevalence rates ranging from 0.1% to 15% in clinical specimens.
Risk factors: Corynebacterium striatum infections include immunosuppression, long-term hospitalization, invasive procedures, indwelling catheters, and broad-spectrum antibiotics.
Treatment: Corynebacterium striatum is typically resistant to penicillin and other beta-lactam antibiotics. It is susceptible to certain antibiotics such as vancomycin, daptomycin, linezolid, and tigecycline. However, antibiotic resistance is becoming increasingly common among clinical isolates.
Corynebacterium striatum is a Gram-positive, aerobic, non-spore-forming bacterium belonging to the Corynebacterium genus. It was first identified in 1993 and is commonly found in the environment and the skin, respiratory tract, and gastrointestinal tract of humans.
Structure:C. striatum is a rod-shaped bacterium that ranges from 0.5 to 0.8 µm in diameter and 1.5 to 5 µm in length. It has a cell wall composed of peptidoglycan, arabinogalactan, and mycolic acids, which gives it a characteristic “club-like” shape. The mycolic acid in the cell wall makes it resistant to many disinfectants and antibiotics.
Classification: C. striatum is a member of the phylum Actinobacteria, class Actinobacteria, order Corynebacteriales, family Corynebacteriaceae, and genus Corynebacterium. It is closely related to Corynebacterium species, such as C. diphtheriae, C. pseudotuberculosis, and C. ulcerans.
C. Striatum can be further classified into biotypes and ribotypes based on its biochemical and genetic characteristics. There are currently nine known biotypes and 13 ribotypes of C. striatum identified, which can be differentiated by their ability to utilize different carbon sources and the genetic diversity of their 16S rRNA genes, respectively.
There are several antigenic types of Corynebacterium striatum, which their specific serotypes can identify. Serotyping is based on specific antigens on the bacterial surface, which can be detected using antibodies. Several serotyping methods exist, including agglutination tests, enzyme-linked immunosorbent assays (ELISAs), and Western blotting.
Which depends on whether something is present or not in specific surface proteins. These types include:
Type A: This type is characterized by the presence of the OmpA, an outer membrane protein.
Type B: This type is characterized by the presence of the protein P48, which is a cell surface protein.
Type C: This type is characterized by the presence of the protein FimA, which is a fimbrial protein.
Type D: This type is characterized by the absence of all three proteins (OmpA, P48, and FimA).
Corynebacterium striatum is a gram-positive, aerobic, non-spore-forming bacterium that is a part of the normal microbiota of human skin and mucous membranes. It is regarded as an opportunistic pathogen; in most cases, it rarely results in sickness in healthy persons. But can cause infections in immunocompromised individuals or those with underlying medical conditions.
The pathogenesis of C. striatum is poorly understood, although it is believed to be associated with the production of virulence factors such as adhesins, invasins, and toxins. Adhesins are molecules that allow the bacteria to adhere to host cells and tissues, while invasins facilitate the entry of the bacteria into host cells. Toxins produced by C. striatum can cause tissue damage and contribute to disease development.
C. Striatum is known to cause various infections, including skin and soft tissue infections, bloodstream infections, and pneumonia. The bacterium is often resistant to multiple antibiotics, making it difficult to treat.
One study found that C. striatum could form biofilms, communities of bacteria that attach to surfaces and resist antibiotics and the host’s immune response. Biofilm formation may contribute to the ability of C. striatum to cause persistent infections.
In conclusion, the pathogenesis of C. striatum is complex and poorly understood, but it is thought to involve the production of virulence factors such as adhesins, invasins, and toxins. The ability of the bacterium to form biofilms may also contribute to its pathogenicity.
The typical microbial flora of the skin and mucous membranes includes Corynebacterium striatum. While it is typically considered a non-pathogenic bacterium, C. striatum has been known to cause opportunistic infections in immunocompromised individuals.
The host defenses against C. striatum include both innate and adaptive immune responses. The initial line of protection against pathogens is the innate immune system. Invading pathogens and is responsible for the initial recognition and response to C. striatum.
The innate immune response to C. striatum includes the activation of various pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs), which recognize pathogen-associated molecular patterns (PAMPs) present on the surface of the bacteria.
This recognition leads to the activation of downstream signaling pathways, producing pro-inflammatory cytokines and chemokines, recruitment of phagocytic cells, and induction of oxidative burst to destroy the bacteria.
The adaptive immune response to C. striatum involves the activation of T and B lymphocytes, which recognize and respond to specific antigens present on the surface of the bacteria. It leads to the production of specific antibodies and the activation of T cells, which can directly kill infected cells or release cytokines that promote the clearance of the bacteria.
In addition to the immune response, host defenses against C. striatum include physical and mechanical barriers, such as the skin and mucous membranes, preventing the bacteria from entering the body. Furthermore, the normal microbial flora of the skin and mucous membranes can compete with C. striatum for nutrients and space, limiting its growth and colonization.
Here are some clinical manifestations of C. striatum infections:
Skin and soft tissue infections: C. striatum can cause cellulitis, abscesses, and wound infections. These infections can be challenging to treat because Several antibiotics frequently fail to kill C. striatum.
Urinary tract infections: C. striatum can cause urinary tract infections in individuals with urinary catheters or other abnormalities.
Respiratory tract infections: C. striatum can cause pneumonia in immunocompromised individuals or have underlying lung disease.
Endocarditis: C. striatum can cause infective endocarditis, an infection of the heart valves. It is a severe condition that requires prompt treatment.
Bacteremia: C. striatum can cause bloodstream infections, leading to sepsis if not treated promptly.
C. Striatum infection can be diagnosed through various methods, including culture, microscopy, biochemical tests, and molecular techniques such as PCR (polymerase chain reaction) and sequencing.
Culture is the most common method used to diagnose C. striatum infection. The bacteria can be grown on various media, including blood, chocolate, and MacConkey agar. The colonies typically appear gray or yellowish and have a “club-shaped” morphology.
Microscopy can also visualize the bacteria, although it is less commonly used than culture. Gram staining can be performed to identify the bacteria as Gram-positive, and the club-shaped morphology can be seen under a microscope.
Biochemical tests can also be used to identify C. striatum. The bacteria are catalase-positive, oxidase-negative, and urease-negative. They also produce acid from glucose and maltose but not from lactose or sucrose.
PCR and sequencing can also identify C. striatum. PCR can be used to amplify specific DNA sequences unique to the bacteria, and sequencing can be used to compare the DNA sequence to known C. striatum sequences in databases.
Corynebacterium striatum is a type of bacteria that can cause infections in humans, especially in immunocompromised individuals. Here are some ways to control its spread:
Hand hygiene: Regularly washing your hands Using alcohol-based hand sanitizer or soap and water can help prevent the spread of C. striatum.
Isolation precautions: Patients infected with C. striatum should be segregated in a private room, and medical personnel caring for patients should wear gloves and gowns.
Antibiotic stewardship: Overusing antibiotics can develop antibiotic-resistant strains of C. striatum. Thus it’s essential only to use antibiotics when necessary.
Environmental cleaning: Frequent cleaning and disinfection of surfaces and equipment can help prevent the spread of C. striatum.
Education and awareness: Healthcare workers and the general public should be educated about the risks associated with C. striatum infections and the measures that can be taken to prevent their spread.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
